article thumbnail

Pharma Spending Gone Bipolar: Generics At One End, Specialty Drugs on the Other

Health Populi

Prescription drug spending on branded products grew nearly $5 billion less than in 2016; generic drug spending fell by $5.5 a report from the IQVIA Institute for Health Data Science. “Growth slowed in 2016 and declined by $5.5 In retail and mail-order channels, net spending fell by 2.1%. There were over 5.8

article thumbnail

Loneliness, Public Policy and AI – Lessons From the UK For the US

Health Populi

These policy recommendations are rooted in a tragedy: the murder of Jo Cox, the Labour MP who was murdered in 2016. And here is an important essay, quite timely to revisit from 2016, from The New Yorker on Jo Cox, the Brexit Vote, and the Politics of Murder. Jo had set up the Commission on Loneliness before she was killed.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

DeepMind Health could gain ?excessive monopoly power? says new report

Lloyd Price

The latest worries are voiced by a panel of external reviewers appointed by the Google-owned AI company to report on its operations after its initial data-sharing arrangements with the U.K.’s s National Health Service (NHS) ran into a major public controversy in 2016. hospitals that don’t actually involve any AI at all.

FHIR 45
article thumbnail

A Matter of Trust, Perception, Risk, and Uncertainty – The Big Issues Raised by the Acquisition of PatientsLikeMe and Other Patient Data Transactions

Health Populi

Interestingly, people don’t ascribe that same power to tech companies, who have so much data on us from so many sources beyond medical claims that it makes insurers look entirely benign. Should it be? Most people want to contribute to the betterment of society, help their fellow humans, and find a way to a healthier life.